主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | 领航集团有限公司 | 是 | 24345.51万 | 10.10% |
|
|
-- |
| 2 | 贝莱德集团公司 | 是 | 18630.83万 | 7.70% | 不变 | 不变 | -- |
| 3 | 美国道富集团 | 是 | 13299.63万 | 5.50% | 不变 | 不变 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2026-02-27 | Decker Robert J |
|
2.78 | 115.67 | 是 | VP Corporate Controller |
| 2026-02-27 | Decker Robert J |
|
2.37 | 247.87 | 是 | VP Corporate Controller |
| 2026-02-20 | Schmid Timothy |
|
2.54 | 245.66 | 是 | EVP, WW Chair, MedTech |
| 2026-02-15 | REED JOHN C |
|
1.07 | 243.00 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
1.20 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
1.16 | 243.45 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
1.35 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
1.29 | 243.45 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
3.47 | 157.92 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
1.29 | 243.00 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
4.29 | 156.15 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-15 | REED JOHN C |
|
1.29 | 243.00 | 是 | EVP, Innovative Medicine, R&D |
| 2026-02-13 | Forminard Elizabeth |
|
1.62 | 0.00 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Forminard Elizabeth |
|
1.59 | 244.55 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Forminard Elizabeth |
|
2.96 | 0.00 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Forminard Elizabeth |
|
2.26 | 244.55 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Forminard Elizabeth |
|
2.35 | 0.00 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Forminard Elizabeth |
|
2.30 | 243.45 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Forminard Elizabeth |
|
2.41 | 0.00 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Forminard Elizabeth |
|
2.36 | 243.45 | 是 | EVP, Chief Legal Officer |
| 2026-02-13 | Duato Joaquin |
|
27.94 | 0.00 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Duato Joaquin |
|
27.84 | 244.55 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Duato Joaquin |
|
35.15 | 0.00 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Duato Joaquin |
|
31.98 | 244.55 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Duato Joaquin |
|
32.35 | 0.00 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Duato Joaquin |
|
32.19 | 243.45 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Duato Joaquin |
|
32.64 | 0.00 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Duato Joaquin |
|
32.44 | 243.45 | 是 | CEO and Chairman of the Board |
| 2026-02-13 | Wengel Kathryn E |
|
10.66 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Wengel Kathryn E |
|
10.64 | 244.55 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Wengel Kathryn E |
|
12.01 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Wengel Kathryn E |
|
11.37 | 244.55 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Wengel Kathryn E |
|
11.43 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Wengel Kathryn E |
|
11.40 | 243.45 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Wengel Kathryn E |
|
11.46 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Wengel Kathryn E |
|
11.43 | 243.45 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-13 | Broadhurst Vanessa |
|
2.40 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
2.39 | 244.55 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
3.25 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
2.87 | 244.55 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
2.92 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
2.89 | 243.45 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
2.95 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
2.92 | 243.45 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Broadhurst Vanessa |
|
2.30 | 243.39 | 是 | EVP, Global Corp Affairs |
| 2026-02-13 | Decker Robert J |
|
2.13 | 0.00 | 是 | VP Corporate Controller |
| 2026-02-13 | Decker Robert J |
|
2.12 | 244.55 | 是 | VP Corporate Controller |
| 2026-02-13 | Decker Robert J |
|
2.40 | 0.00 | 是 | VP Corporate Controller |
| 2026-02-13 | Decker Robert J |
|
2.32 | 244.55 | 是 | VP Corporate Controller |
| 2026-02-13 | Decker Robert J |
|
2.35 | 0.00 | 是 | VP Corporate Controller |
| 2026-02-13 | Decker Robert J |
|
2.38 | 0.00 | 是 | VP Corporate Controller |
| 2026-02-13 | Schmid Timothy |
|
2.26 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
2.70 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
2.52 | 244.55 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
2.68 | 244.53 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
2.62 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
2.72 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Mulholland Kristen |
|
1.93 | 244.55 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Mulholland Kristen |
|
1.97 | 0.00 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Mulholland Kristen |
|
1.95 | 243.45 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Mulholland Kristen |
|
2.01 | 0.00 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Schmid Timothy |
|
2.68 | 243.45 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
4.04 | 115.67 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
2.68 | 244.20 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Schmid Timothy |
|
3.58 | 129.51 | 是 | EVP, WW Chair, MedTech |
| 2026-02-13 | Taubert Jennifer L |
|
17.93 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Taubert Jennifer L |
|
17.89 | 244.55 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Taubert Jennifer L |
|
20.63 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Taubert Jennifer L |
|
19.28 | 244.55 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Taubert Jennifer L |
|
19.44 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Taubert Jennifer L |
|
19.35 | 243.45 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Taubert Jennifer L |
|
19.54 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Taubert Jennifer L |
|
19.45 | 243.45 | 是 | EVP, WWC. Innovative Medicine |
| 2026-02-13 | Wolk Joseph J |
|
5.15 | 0.00 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.55 | 244.55 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.73 | 0.00 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.68 | 244.55 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.88 | 0.00 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.79 | 243.45 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.98 | 0.00 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.90 | 243.45 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
5.82 | 115.67 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.90 | 242.99 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
5.10 | 129.51 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.90 | 242.87 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
7.23 | 131.94 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
3.90 | 242.75 | 是 | Exec VP, CFO |
| 2026-02-13 | Wolk Joseph J |
|
1.40 | 242.68 | 是 | Exec VP, CFO |
| 2026-02-13 | Mulholland Kristen |
|
1.68 | 0.00 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Mulholland Kristen |
|
1.67 | 244.55 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Mulholland Kristen |
|
2.03 | 0.00 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Mulholland Kristen |
|
1.98 | 243.45 | 是 | EVP, Chief HR Officer |
| 2026-02-13 | Swanson James D. |
|
1.93 | 0.00 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
1.92 | 244.55 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.86 | 0.00 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.50 | 244.55 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
4.44 | 165.89 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.50 | 243.76 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
4.72 | 162.75 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.50 | 243.71 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.55 | 0.00 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.53 | 243.45 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.60 | 0.00 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.57 | 243.45 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
4.62 | 164.62 | 是 | EVP, CIO |
| 2026-02-13 | Swanson James D. |
|
2.57 | 242.70 | 是 | EVP, CIO |
| 2026-02-06 | Wengel Kathryn E |
|
13.32 | 101.87 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-06 | Wengel Kathryn E |
|
10.60 | 239.99 | 是 | EVP, Chief TO and Risk Officer |
| 2026-02-06 | Mulholland Kristen |
|
1.97 | 101.87 | 是 | EVP, Chief HR Officer |
| 2026-02-06 | Mulholland Kristen |
|
1.64 | 239.99 | 是 | EVP, Chief HR Officer |
| 2026-02-06 | Schmid Timothy |
|
3.25 | 101.87 | 是 | EVP, WW Chair, MedTech |
| 2026-02-06 | Schmid Timothy |
|
2.21 | 239.99 | 是 | EVP, WW Chair, MedTech |
| 2026-02-05 | Forminard Elizabeth |
|
2.18 | 129.51 | 是 | EVP, Chief Legal Officer |
| 2026-02-05 | Forminard Elizabeth |
|
1.55 | 237.90 | 是 | EVP, Chief Legal Officer |
| 2025-11-26 | MORIKIS JOHN G |
|
0.18 | 206.15 | 是 | -- |
| 2025-10-17 | REED JOHN C |
|
3.24 | 157.92 | 是 | EVP, Innovative Medicine, R&D |
| 2025-10-17 | REED JOHN C |
|
1.07 | 192.71 | 是 | EVP, Innovative Medicine, R&D |
| 2025-09-04 | Taubert Jennifer L |
|
17.80 | 177.81 | 是 | EVP, WWC. Innovative Medicine |
| 2025-09-04 | Taubert Jennifer L |
|
23.45 | 101.87 | 是 | EVP, WWC. Innovative Medicine |
| 2025-08-29 | Forminard Elizabeth |
|
2.24 | 115.67 | 是 | Executive VP, General Counsel |
| 2025-08-29 | Forminard Elizabeth |
|
1.29 | 177.20 | 是 | Executive VP, General Counsel |
| 2025-08-22 | Duato Joaquin |
|
40.18 | 101.87 | 是 | CEO and Chairman of the Board |
| 2025-08-22 | Duato Joaquin |
|
27.60 | 179.21 | 是 | CEO and Chairman of the Board |
| 2025-08-15 | Wolk Joseph J |
|
3.08 | 101.87 | 是 | Exec VP, CFO |
| 2025-08-15 | Wolk Joseph J |
|
1.40 | 176.91 | 是 | Exec VP, CFO |
| 2025-07-17 | REED JOHN C |
|
1.07 | 163.55 | 是 | EVP, Innovative Medicine, R&D |
| 2025-05-01 | REED JOHN C |
|
4.08 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2025-05-01 | REED JOHN C |
|
2.98 | 156.31 | 是 | EVP, Innovative Medicine, R&D |
| 2025-03-18 | Duato Joaquin |
|
27.60 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-25 | Decker Robert J |
|
2.80 | 101.87 | 是 | VP Corporate Controller |
| 2025-02-25 | Decker Robert J |
|
2.10 | 165.88 | 是 | VP Corporate Controller |
| 2025-02-15 | REED JOHN C |
|
1.59 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2025-02-15 | REED JOHN C |
|
1.55 | 156.15 | 是 | EVP, Innovative Medicine, R&D |
| 2025-02-14 | Schmid Timothy |
|
1.79 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-14 | Schmid Timothy |
|
1.69 | 156.71 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Broadhurst Vanessa |
|
2.02 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.01 | 155.26 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.19 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.13 | 156.71 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.18 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.17 | 156.15 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.46 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.36 | 156.71 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Duato Joaquin |
|
39.25 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.10 | 155.26 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.60 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.38 | 156.71 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.75 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.59 | 156.15 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
41.52 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
40.68 | 156.71 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Decker Robert J |
|
1.93 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
1.92 | 155.26 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
2.00 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
1.98 | 156.71 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
2.01 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Forminard Elizabeth |
|
0.90 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
0.88 | 155.26 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.00 | 156.15 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.14 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.09 | 156.71 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
0.96 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
0.94 | 156.71 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.03 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Decker Robert J |
|
2.14 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
2.10 | 156.71 | 是 | VP Corporate Controller |
| 2025-02-13 | Mulholland Kristen |
|
1.21 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.20 | 155.26 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.30 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.27 | 156.71 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.31 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.30 | 156.15 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.46 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.41 | 156.71 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Taubert Jennifer L |
|
16.72 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
16.68 | 155.26 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.09 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
16.95 | 156.71 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.11 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.05 | 156.15 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
18.59 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.80 | 156.71 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Swanson James D. |
|
1.50 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.49 | 155.26 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.68 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.63 | 156.71 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.68 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.66 | 156.15 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.97 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.88 | 156.71 | 是 | EVP, CIO |
| 2025-02-13 | Wolk Joseph J |
|
0.18 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.13 | 155.26 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.53 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.41 | 156.71 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.61 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.53 | 156.15 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
2.07 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
1.40 | 156.71 | 是 | Exec VP, CFO |
| 2025-02-13 | Wengel Kathryn E |
|
8.96 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
8.94 | 155.26 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.09 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.04 | 156.71 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.10 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.08 | 156.15 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.67 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.43 | 156.71 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Schmid Timothy |
|
1.35 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.33 | 155.26 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.51 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.45 | 156.71 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.55 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.51 | 156.15 | 是 | EVP, WW Chair, MedTech |
| 2025-02-07 | Taubert Jennifer L |
|
21.34 | 100.06 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-07 | Taubert Jennifer L |
|
16.59 | 153.12 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-07 | Wengel Kathryn E |
|
11.50 | 100.06 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-07 | Wengel Kathryn E |
|
8.90 | 153.12 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-07 | Duato Joaquin |
|
48.97 | 100.06 | 是 | CEO and Chairman of the Board |
| 2025-02-07 | Duato Joaquin |
|
38.90 | 153.12 | 是 | CEO and Chairman of the Board |
| 2024-12-12 | WEINBERGER MARK A |
|
0.10 | 147.22 | 是 | -- |
| 2024-08-30 | Decker Robert J |
|
2.46 | 100.06 | 是 | VP Corporate Controller |
| 2024-08-30 | Decker Robert J |
|
1.90 | 165.06 | 是 | VP Corporate Controller |
| 2024-07-08 | Broadhurst Vanessa |
|
2.49 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2024-07-08 | Broadhurst Vanessa |
|
1.98 | 147.16 | 是 | EVP, Global Corp Affairs |
| 2024-05-22 | Wolk Joseph J |
|
-- | 0.00 | 是 | Exec VP, CFO |
| 2024-05-01 | REED JOHN C |
|
2.26 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2024-05-01 | REED JOHN C |
|
1.46 | 144.59 | 是 | EVP, Innovative Medicine, R&D |